Cardiology Today | This installment of Pipeline Pulse focuses on a single cardiovascular risk factor, lipoprotein(a), and examines two CV outcomes trials aimed at reducing CV events through Lp(a) reduction.Lipoprotein(a), or Lp(a), is produced in the liver and contains two units connected by a covalent disulfide bond, a small LDL-like component and a single apolipoprotein(a) molecule. The apo(a)...
Yes, get it checked. Many new drugs are coming